Related references
Note: Only part of the references are listed.Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
Alexander Radbruch et al.
NEURO-ONCOLOGY (2015)
Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors
Clemens Kratochwil et al.
NEURO-ONCOLOGY (2014)
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients
Ken Herrmann et al.
NEURO-ONCOLOGY (2014)
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
T. Nihashi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?
Ashish H. Shah et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Marion Rapp et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
Nathalie L. Jansen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Brain Tumors
Karl Herholz et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading Assessment of Individual Probability of Malignancy
Maria Lucia Calcagni et al.
CLINICAL NUCLEAR MEDICINE (2011)
PET and SPECT Studies of Brian Tumors with Radiolabeled Amino Acids
K. -J Langen et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2011)
Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI
Yong Hwy Kim et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
3'-Deoxy-3'-[18F] fluorothymidine and O-(2-[18F] fluoroethyl)L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study
Su Young Jeong et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Pseudoprogression and pseudoresponse in the treatment of gliomas
Dieta Brandsma et al.
CURRENT OPINION IN NEUROLOGY (2009)
Differential Diagnosis Between Radiation Necrosis and Glioma Progression Using Sequential Proton Magnetic Resonance Spectroscopy and Methionine Positron Emission Tomography
Takeshi Nakajima et al.
NEUROLOGIA MEDICO-CHIRURGICA (2009)
The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment
J. H. Mehrkens et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
FET PET for the evaluation of untreated gliomas:: correlation of FET uptake and uptake kinetics with tumour grading
Gabriele Poepperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Non-invasive grading of brain tumours using dynamic amino acid PET imaging:: does it work for 11C-Methionine?
Gerard Moulin-Romsee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas
W Rachinger et al.
NEUROSURGERY (2005)
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours
M Weckesser et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Direct comparison of F-18-FDG and C-11-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
K Van Laere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery - In malignant glioma
N Tsuyuguchi et al.
ANNALS OF NUCLEAR MEDICINE (2004)
Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma
G Pöpperl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine
K Hamacher et al.
APPLIED RADIATION AND ISOTOPES (2002)
Share Paper
